冠状动脉CT血管成像在动脉粥样硬化风险评估与预防性护理中的进展
本文综述了基于冠状动脉CT血管成像(CTA)自动测量动脉粥样硬化的近期进展,指出自动狭窄测量具有合理准确性,斑块定量与血管内超声测量总斑块体积高度一致(r>0.90),但较小斑块体积统计方差更高;定量分析有助于改善风险预测,但仍需更多证据明确高危患者并确定其增量价值。
要点
- 冠状动脉CTA自动狭窄测量具有合理准确性,但按部位、血管大小或图像质量分层的变异性证据尚不明确。
- 冠状动脉CTA与血管内超声测量总斑块体积高度一致(r>0.90),较小斑块体积的统计方差更高。
- 排除较小动脉的定量方案会影响女性、糖尿病患者及其他患者亚组的准确性。
核心结论
- 冠状动脉CTA动脉粥样硬化定量分析具有应用前景,尤其可能有助于对非阻塞性冠状动脉疾病和高危斑块特征患者进行针对性的更强化心血管预防。
- 定量分析有助于改善风险预测的证据正在积累,但仍需更多证据来定义不同人群中的高危患者,并确定该信息是否对风险因素或当前使用的冠状动脉CT技术(如冠状动脉钙化评分或斑块负荷/狭窄的视觉评估)具有增量价值。
研究设计与样本
- 综述类文章,检索范围与纳入文献未在原文摘要中报告。
关键影像表现/征象
- 原文未涉及具体影像征象描述。
诊断标准与关键数值
- 冠状动脉CTA与血管内超声测量总斑块体积高度一致(r>0.90)。
- 较小斑块体积的统计方差更高。
临床应用与阅片要点
- 自动狭窄测量具有合理准确性,但按部位、血管大小或图像质量分层的变异性证据尚不明确。
- 冠状动脉尺寸随年龄、性别、心脏大小、冠状动脉优势型及种族和民族而异;排除较小动脉的定量方案会影响女性、糖尿病患者及其他患者亚组的准确性。
- 定量分析需提供足够增量价值以改善患者护理,同时以最小且合理的成本减轻患者和医疗系统的经济负担。
局限性
- 自动狭窄测量按部位、血管大小或图像质量分层的变异性证据尚不明确。
- 关于技术或患者特异性因素如何导致按成分亚组测量变异性的数据有限。
- 仍需更多证据来定义不同人群中的高危患者,并确定定量信息是否对风险因素或当前使用的冠状动脉CT技术具有增量价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The diagnostic evaluation of coronary artery disease is undergoing a dramatic transformation with a new focus on atherosclerotic plaque. This review details the evidence needed for effective risk stratification and targeted preventive care based on recent advances in automated measurement of atherosclerosis from coronary computed tomography angiography (CTA). To date, research findings support that automated stenosis measurement is reasonably accurate, but evidence on variability by location, artery size, or image quality is unknown. The evidence for quantification of atherosclerotic plaque is unfolding, with strong concordance reported between coronary CTA and intravascular ultrasound measurement of total plaque volume (r >0.90). Statistical variance is higher for smaller plaque volumes. Limited data are available on how technical or patient-specific factors result in measurement variability by compositional subgroups. Coronary artery dimensions vary by age, sex, heart size, coronary dominance, and race and ethnicity. Accordingly, quantification programs excluding smaller arteries affect accuracy for women, patients with diabetes, and other patient subsets. Evidence is unfolding that quantification of atherosclerotic plaque is useful to enhance risk prediction, yet more evidence is required to define high-risk patients across varied populations and to determine whether such information is incremental to risk factors or currently used coronary computed tomography techniques (eg, coronary artery calcium scoring or visual assessment of plaque burden or stenosis). In summary, there is promise for the utility of coronary CTA quantification of atherosclerosis, especially if it can lead to targeted and more intensive cardiovascular prevention, notably for those patients with nonobstructive coronary artery disease and high-risk plaque features. The new quantification techniques available to imagers must not only provide sufficient added value to improve patient care, but also add minimal and reasonable cost to alleviate the financial burden on our patients and the health care system.
引用
- Bienstock, Lin, Blankstein, et al. Advances in Coronary Computed Tomographic Angiographic Imaging of Atherosclerosis for Risk Stratification and Preventive Care. JACC Cardiovasc Imaging. 2023. PMID: 37178070. doi:10.1016/j.jcmg.2023.02.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。